Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity
Manuel Mântua E Garcia, Virginie Xavier, Ricardo C Calhelha, Sandrina A Heleno · 2026
Read Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity by Manuel Mântua E Garcia, Virginie Xavier, Ricardo C Calhelha, Sandrina A Heleno (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13437617.txt.
Description
Manuel Garcia and co-authors reviewed how cholesterol-lowering agents talk with the gut's microbial community. High cholesterol drives heart disease, and its treatments do more than trim blood fat. Their 2026 review gathered work on eleven such agents, synthetic drugs and natural compounds, and judged how strongly each reshapes gut bacteria and how firm the proof is.
With few exceptions, treatments shifted the gut mix. Community diversity changed and a headline ratio between two bacterial groups fell. At finer levels, changes clustered by how each drug works and how much reaches the gut. The new mixes favored bacteria brewing short-chain fatty acids over types tied to inflammation. For some agents, gut microbes also broke the drug down into active products, meaning part of the benefit may run through the gut itself. The authors see room for gut-aware cholesterol care, yet stress that cause and effect are not proven.
Catalog record
| CREATOR | Manuel Mântua E Garcia, Virginie Xavier, Ricardo C Calhelha, Sandrina A Heleno |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 83974 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |